5-hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention

Trends in Neurosciences

Volumn 30, Issue 2, 2007, Pages 79-84

  Giuliano, François ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 HYDROXYTRYPTOPHAN; CITALOPRAM; CLOMIPRAMINE; DAPOXETINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA; BRAIN REGION; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG MECHANISM; EJACULATION; EJACULATION DISORDER; HUMAN; INSOMNIA; MENTAL DISEASE; NAUSEA; NEUROANATOMY; PHYSIOLOGY; POSTSYNAPTIC INHIBITION; PREMATURE EJACULATION; PRIORITY JOURNAL; REVIEW; SPINE; THERAPY EFFECT; TREATMENT DURATION; XEROSTOMIA;

ANIMALS; DEPRESSION; EJACULATION; HUMANS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 33846488010     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.12.002     Document Type: Review

References (49)

1. Laumann E.O., et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int. J. Impot. Res. 17 (2005) 39-57
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edn (1994), American Psychiatric Association
3. Lue T.F., et al. Summary of the recommendations on sexual dysfunctions in men. J. Sex Med. 1 (2004) 6-23
4. Waldinger M.D., and Schweitzer D.H. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I - Validity of DSM-IV-TR. J. Sex Med. 3 (2006) 682-692
5. Althof S.E. Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J. Urol. 175 (2006) 842-848
6. Levin R.J. The mechanisms of human ejaculation - a critical analysis. Sexual. Relat. Ther. 20 (2005) 123-131
7. Brindley G. Physiology of erection and management of paraplegic infertility. In: Hargreave T.B. (Ed). Male infertility (1983), Springer-Verlag 262-278
8. Gerstenberg T.C., et al. Erection and ejaculation in man. Assessment of the electromyographic activity of the bulbocavernosus and ischiocavernosus muscles. Br. J. Urol. 65 (1990) 395-402
9. Coolen L.M., et al. Central control of ejaculation. Physiol. Biochem. Behav. 83 (2004) 203-218
10. Xu C., et al. Identification of the lumbar spinal interneurons controlling both prostate and bulbospongiosus muscle simultaneous with two strains of recombinants pseudorabies virus in male rat. Neuroscience 138 (2006) 561-573
11. Holstege G., et al. Brain activation during human male ejaculation. J. Neurosci. 23 (2003) 9185-9193
12. Baum M.J., and Everitt B.J. Increased expression of c-fos in the medial preoptic area after mating in male rats: role of afferent inputs from the medial amygdala and midbrain central tegmental field. Neuroscience 50 (1992) 627-646
13. Coolen L.M., et al. Fos immunoreactivity in the rat brain following consummatory elements of sexual behaviour: a sex comparison. Brain Res. 738 (1996) 67-82
14. Hamson D.K., and Watson N.V. Regional brainstem expression of Fos associated with sexual behavior in male rats. Brain Res. 1006 (2004) 233-240
15. Giuliano F., and Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur. Urol. 48 (2005) 408-417
16. Waldinger M.D., et al. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav. Brain Res. 92 (1998) 111-118
17. Marson L., and McKenna K.E. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Exp. Brain Res. 88 (1992) 313-320
18. de Jong T.R., et al. Serotonin and the neurobiology of the ejaculatory threshold. Neurosci. Biobehav. Rev. 30 (2006) 893-907
19. Kim S.W., and Paick J.S. Peripheral effects of serotonin on the contractile responses of rat seminal vesicles and vasa deferentia. J. Androl. 25 (2004) 893-899
20. Fabre L.F., and Putman III H.P. A fixed-dose clinical trial of fluoxetine in outpatients with major depression. J. Clin. Psychiatry 48 (1987) 406-408
21. Levine S., et al. A comparative trial of a new antidepressant, fluoxetine. Br. J. Psychiatry 150 (1987) 653-655
22. Wong D.T., et al. Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat. Rev. Drug Discov. 4 (2005) 764-774
23. Lane R.M. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J. Psychopharmacol. 11 (1997) 72-82
24. Adson D.E., and Kotlyar M. Premature ejaculation associated with citalopram withdrawal. Ann. Pharmacother. 37 (2003) 1804-1806
25. Rosen R.C., et al. Effects of SSRIs on sexual function: a critical review. J. Clin. Psychopharmacol. 19 (1999) 67-85
26. Stone K.J., et al. Off-label applications for SSRIs. Am. Fam. Physician 68 (2003) 495-504
27. Waldinger M.D., et al. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int. J. Impot. Res. 16 (2004) 369-381
28. 1 autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci. 23 (2000) 459-465
29. Quintin P., and Thomas P. Efficacy of atypical antipsychotics in depressive syndromes. Encephale 30 (2004) 583-589
30. Olivier B., et al. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int. Clin. Psychopharmacol. 13 Suppl. 6 (1998) S9-S14
31. Waldinger M.D., et al. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J. Sex Med. 2 (2005) 120-131
32. Montejo-Gonzalez A.L., et al. SSRI-induced sexual dysfunction: floxetine, paroxetine, sertraline and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J. Sex Marital Ther. 23 (1997) 176-194
33. Waldinger M.D., et al. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur. Urol. 46 (2004) 510-515
34. Waldinger M.D., et al. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J. Clin. Psychopharmacol. 21 (2001) 293-297
35. McMahon C.G., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J. Urol. 161 (1999) 1826-1830
36. Seo K.K., et al. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies. J. Urol. 165 (2001) 2110-2114
37. Modi N.B., et al. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J. Clin. Pharmacol. 46 (2006) 301-309
38. Pryor J.L., et al. Dapoxetine study group. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 368 (2006) 929-937
39. 1A autoreceptors. Br. J. Pharmacol. 114 (1995) 357P
40. Fuller R.W., et al. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol. Biochem. Behav. 30 (1988) 715-721
41. Cohen P.G., and Holbrook J.M. Effects of fenfluramine on ejaculatory function, luteinizing hormone and testosterone levels in men with hypogonadotropic hypogonadism and premature ejaculation. Int. Clin. Psychopharmacol. 14 (1999) 91-94
42. Adell A., et al. Strategies for producing faster acting antidepressants. Drug Discov. Today 10 (2005) 578-585
43. de Jong T.R., et al. Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity. Eur. J. Pharmacol. 509 (2005) 49-59
44. 1B receptor antagonist critically depends on the dose of citalopram. Eur. J. Pharmacol. 26 (2000) 63-74
45. Waldinger M.D., et al. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav. Brain Res. 92 (1998) 111-118
46. 1B receptor and antidepressant effect of selective serotonin reuptake inhibitors. C. R. Seances Soc. Biol. Fil. 192 (1998) 1139-1147
47. 1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br. J. Pharmacol. 125 (1998) 1733-1743
48. 1B receptors in the inhibition of male rat ejaculatory behaviour produced by 5-HTP. Psychopharmacology (Berl.) 137 (1988) 374-382
49. Sleight A.J., et al. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol. Pharmacol. 47 (1995) 99-103